UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Sofosbuvir for treatment of chronic hepatitis C

Hepatology international, 2015-04, Vol.9 (2), p.161-173

2015

Volltextzugriff (PDF)

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Clinical infectious diseases, 2021-07, Vol.73 (1), p.e119-e121

2021

Volltextzugriff (PDF)

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

Addiction science & clinical practice, 2024-03, Vol.19 (1), p.22-5, Article 22

2024

Volltextzugriff (PDF)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Open forum infectious diseases, 2022-10, Vol.9 (10), p.ofac476-ofac476

2022

Volltextzugriff (PDF)

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

World journal of hepatology, 2016-11, Vol.8 (31), p.1318-1326

2016

Volltextzugriff (PDF)

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Journal of addiction medicine, 2021-11, Vol.15 (6), p.452

2021

Volltextzugriff (PDF)

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Annals of internal medicine, 2017-09, Vol.167 (5), p.311

2017

Volltextzugriff (PDF)

Opioids and Infectious Diseases: A Converging Public Health Crisis

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.346-349

2019

Volltextzugriff (PDF)

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1715-1722

2020

Volltextzugriff (PDF)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Addiction (Abingdon, England), 2024-07

2024

Volltextzugriff (PDF)

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

The Journal of infectious diseases, 2017-12, Vol.217 (1), p.47-50

2017

Volltextzugriff (PDF)

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Journal of hepatology, 2019-09, Vol.71 (3), p.498-504

2019

Volltextzugriff (PDF)

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

Health services research, 2023-08, Vol.58 (4), p.865-872

2023

Volltextzugriff (PDF)

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

AIDS (London), 2023-10, Vol.37 (12), p.1799

2023

Volltextzugriff (PDF)

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Clinical microbiology reviews, 2017-01, Vol.30 (1), p.23-42

2017

Volltextzugriff (PDF)

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Clinical infectious diseases, 2019-08, Vol.69 (4), p.571-576

2019

Volltextzugriff (PDF)

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

The International journal of drug policy, 2023-01, Vol.111, p.103906-103906, Article 103906

2023

Volltextzugriff (PDF)

Hepatitis C genotype 3 disease

Hepatology international, 2016-11, Vol.10 (6), p.861-870

2016

Volltextzugriff (PDF)

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Clinical infectious diseases, 2016-02, Vol.62 (3), p.280-288

2016

Volltextzugriff (PDF)

A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting

The Journal of the Association of Nurses in AIDS Care, 2017-09, Vol.28 (5), p.680-684

2017

Volltextzugriff (PDF)

The Effect of GS‐548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS‐6637 in Healthy Adults

Journal of clinical pharmacology, 2020-12, Vol.60 (12), p.1598-1605

2020

Volltextzugriff (PDF)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder

JAMA network open, 2021-08, Vol.4 (8), p.e2118487-e2118487

2021

Volltextzugriff (PDF)

Acute Limb Ischemia Caused by Inadvertent Arterial Drug Self-Injection: A Case Report

The American journal of case reports, 2021-08, Vol.22, p.e932903-e932903

2021

Volltextzugriff (PDF)

Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti–Hepatitis C Virus Therapy in Patients With Advanced Liver Disease

Clinical infectious diseases, 2016-02, Vol.62 (4), p.440-447

2016

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Sofosbuvir for treatment of chronic hepatitis C

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Opioids and Infectious Diseases: A Converging Public Health Crisis

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

Hepatitis C genotype 3 disease

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting

The Effect of GS‐548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS‐6637 in Healthy Adults

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder

Acute Limb Ischemia Caused by Inadvertent Arterial Drug Self-Injection: A Case Report

Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti–Hepatitis C Virus Therapy in Patients With Advanced Liver Disease

Aktive Filter

Suchergebnisse filtern